# Pedagogical Review: Drug Discovery (Chapter 29)

Generated: 2026-01-06
File: `part_6/p6-ch29-drug-discovery.qmd`
Word count: ~6,500 (original), ~7,800 (enhanced)

## Executive Summary

Chapter 29 on Drug Discovery had strong foundational content with an excellent narrative hook (90% clinical trial failure rate) and well-organized sections covering the drug discovery pipeline. However, the chapter lacked metacognitive scaffolds (no learning objectives, no summary), retrieval practice opportunities, and explicit cross-chapter connections. The enhanced version adds comprehensive pedagogical elements including a Chapter Overview with prerequisites and 7 learning objectives, 5 retrieval practice prompts (Stop and Think / Knowledge Check), 3 Key Insight callouts, 2 comparison tables, 2 practical guidance callouts, difficulty warnings, and a comprehensive Chapter Summary.

## Learning Science Scorecard

| Principle | Before | After | Key Changes |
|-----------|--------|-------|-------------|
| Cognitive Load | B | A | Added tables to organize complex comparisons; chunked industry section |
| Retrieval Practice | D | A | Added 5 retrieval prompts throughout (Stop and Think, Knowledge Check) |
| Interleaving | B | A | Added explicit comparison table for variant-to-gene evidence types |
| Spacing | B | A | Strengthened forward/backward cross-references throughout |
| Elaborative Interrogation | B | B+ | Already strong; Key Insight callouts emphasize "why" |
| Concrete Examples | B | B+ | Original examples retained; practical guidance adds context |
| Dual Coding | B | B | Figure placeholders already present; no changes needed |
| Prior Knowledge Activation | C | A | Added Chapter Overview with explicit prerequisites |
| Metacognitive Scaffolds | D | A | Added learning objectives, difficulty warnings, Chapter Summary |
| Desirable Difficulties | C | A | Added prediction prompts before explanations |
| Hooks & Narrative | A | A | Excellent opening already; no changes needed |
| Transfer & Application | B | A | Added practical guidance callouts with real-world application |

**Overall Pedagogical Grade: Before B- / After A**

## Enhancements Implemented

### 1. Chapter Overview (Lines 3-19)
Added comprehensive callout with:
- Prerequisites linking to 6 prior chapters (VEP, protein LMs, regulatory FMs, networks, GWAS, fine-mapping, confounding)
- 7 specific learning objectives aligned with chapter content
- Estimated reading time (45-60 minutes)

### 2. Retrieval Practice Prompts (5 total)
| Location | Type | Topic |
|----------|------|-------|
| Line 49-53 | Stop and Think | Variant-to-target conversion challenge |
| Line 81-85 | Knowledge Check | Evaluating pleiotropic high-constraint targets |
| Line 137-141 | Stop and Think | PLM embeddings for structure-free binding prediction |
| Line 207-211 | Knowledge Check | Library design for constrained vs. uncertain regions |
| Line 259-263 | Stop and Think | FM embeddings vs. binary genotypes in PGS |

### 3. Key Insight Callouts (3 total)
| Location | Topic | Pedagogical Purpose |
|----------|-------|---------------------|
| Lines 25-29 | Genetic Validation Advantage | Highlights foundational 2x success rate finding |
| Lines 97-101 | Single-Gene vs. Network Evidence | Contrasts two paradigms for target discovery |
| Lines 233-237 | Bayesian Lab-in-the-Loop | Provides conceptual framework for iterative refinement |

### 4. Comparison Tables (2 total)
- **Table @tbl-variant-to-gene-evidence** (Lines 61-69): Evidence types for variant-to-gene mapping with strengths/limitations
- **Table @tbl-build-buy-finetune** (Lines 295-301): Strategic options for FM adoption in industry

### 5. Practical Guidance Callouts (2 total)
- **Genetic Safety Signals** (Lines 163-175): 5-step checklist for evaluating target safety
- **Aligning FM Work with Drug Development Gates** (Lines 317-329): Gate-by-gate FM contributions table

### 6. Difficulty Warning (Lines 223-227)
Added warning before "Lab-in-the-Loop" section flagging active learning and uncertainty quantification as advanced topics requiring prior knowledge.

### 7. Chapter Summary (Lines 379-402)
Comprehensive summary with:
- 8 core concepts with brief definitions
- 5 key themes emphasizing critical principles
- Explicit connections to prior and subsequent chapters

### 8. Cross-Reference Strengthening
Enhanced cross-references added:
- Prerequisites in overview: @sec-ch17-vep-fm, @sec-ch15-esm-family, @sec-ch16-enformer, @sec-ch21-networks, @sec-ch03-gwas, @sec-ch03-fine-mapping, @sec-ch12-confounding
- Warning callout: @sec-ch23-epistemic, @sec-ch09-full-finetuning
- Chapter Summary connections: @sec-ch17-vep-fm, @sec-ch21-networks, @sec-ch12-confounding, @sec-ch30-design

## Recommendations for Future Revisions

### Medium Priority
1. **Add worked example**: Consider a step-by-step target prioritization example for a specific disease (e.g., Crohn's disease) showing the full pipeline from GWAS to ranked targets
2. **Expand clinical case**: The chapter mentions QT prolongation and hepatotoxicity markers but could benefit from a concrete case where genetic evidence predicted (or failed to predict) a safety signal

### Low Priority
3. **Interactive elements**: If converted to digital format, the retrieval prompts could become interactive quizzes with feedback
4. **Figure enhancement**: When placeholder figures are replaced, ensure figure captions provide explanatory context, not just labels

## Quality Metrics

| Metric | Before | After |
|--------|--------|-------|
| Callout boxes | 0 | 12 |
| Retrieval prompts | 0 | 5 |
| Tables | 0 | 2 |
| Explicit prerequisites | 0 | 6 |
| Learning objectives | 0 | 7 |
| Cross-references to other chapters | ~25 | ~35 |
| Practical guidance sections | 0 | 2 |
| Difficulty warnings | 0 | 1 |

---

*Report generated by pedagogy-review agent*
